ALPHAPORT.AI
🇹🇼VISCO6782
TWDUSD
SectorHealth CareIndustryBiotechWebsitehttps://www.viscovision.com.tw
Management
李重儀
CEO

Company information

Ticker
6782
Country
Taiwan
Sector
Health Care
Industry
Biotech

VISCO Business Summary

Visco Vision Inc. (6782.TW) is a premier global Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) specializing in high-performance silicone hydrogel (SiHy) contact lenses. The company generates revenue through the mass production of disposable lenses, including spherical, toric, multifocal, and cosmetic color variants, with a strategic focus on high-oxygen permeability materials. As of early 2026, Visco is aggressively expanding its manufacturing footprint, targeting a monthly production capacity of 52 million pieces by Q3 2026 following a significant NT$468 million property acquisition in Taoyuan. Its primary revenue streams are geographically diversified across Asia and Europe, positioning the firm as a critical supply chain partner for international vision care brands. Visco competes directly with industry leaders such as Johnson & Johnson Vision, Alcon, and CooperVision, as well as regional specialized peers like Pegavision Corporation and St. Shine Optical, maintaining a competitive edge through proprietary material science and the largest SiHy-dedicated production capacity in Asia. The company is led by Chairman and CEO Chung-I (James) Lee, a veteran executive with a Ph.D. in Electrical Engineering from the University of California and a professional pedigree that includes senior leadership roles at Qualcomm and BenQ Corporation’s mobile division. Visco operates as a core entity within the BenQ/Qisda Group ecosystem, benefiting from shared technological synergies and global logistics networks. The leadership team is supported by a board featuring representatives from major institutional shareholders, most notably BenQ Materials Corp, which holds a 14.82% stake, and individual investor K.Y. Lee. Key executives, including Vice President Cang-Song Wu and CFO Sharon Cheng, oversee a lean operational structure focused on R&D and regulatory compliance, ensuring the firm remains a dominant force in the high-barrier silicone hydrogel market.

Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.